These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24350318)

  • 21. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of nephropathy in patients with type 2 diabetes.
    Critchley JA; Zhao HL; Tomlinson B; Leung W; Thomas GN; Chan JC; Cockram CS
    Chin Med J (Engl); 2002 Jan; 115(1):129-35. PubMed ID: 11930647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
    Hughes DB; Britton ML
    Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of angiotensin-converting enzyme inhibitors in patients with diabetic nephropathy.
    How HY; Sibai BM
    J Matern Fetal Neonatal Med; 2002 Dec; 12(6):402-7. PubMed ID: 12683651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The emerging concept of chronic kidney disease without clinical proteinuria in diabetic patients.
    Halimi JM
    Diabetes Metab; 2012 Oct; 38(4):291-7. PubMed ID: 22622176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial nitric oxide synthase gene polymorphisms and renal responsiveness to RAS inhibition therapy in type 2 diabetic Asian Indians.
    Cheema BS; Kohli HS; Sharma R; Bhansali A; Khullar M
    Diabetes Res Clin Pract; 2013 Mar; 99(3):335-42. PubMed ID: 23260854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evidence-based review of ACE inhibitors in incipient diabetic nephropathy.
    Haider A; Oh P; Peloso PM
    Can J Clin Pharmacol; 2000; 7(2):115-9. PubMed ID: 10958708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan): Rationale and study design.
    Shikata K; Haneda M; Koya D; Suzuki Y; Tomino Y; Yamada K; Maeda S; Kawakami N; Uzu T; Nishimura M; Sato C; Ogawa D; Makino H;
    Diabetes Res Clin Pract; 2010 Feb; 87(2):228-32. PubMed ID: 19889469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study.
    Remuzzi G; Macia M; Ruggenenti P
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S90-7. PubMed ID: 16565256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplantation in diabetic kidney failure patients: modalities, outcomes, and clinical management.
    Luan FL; Samaniego M
    Semin Dial; 2010; 23(2):198-205. PubMed ID: 20374550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteinuria and microalbuminuria in adults: significance, evaluation, and treatment.
    Venkat KK
    South Med J; 2004 Oct; 97(10):969-79. PubMed ID: 15558924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventing end-stage renal disease in diabetic patients - dual blockade of the renin-angiotensin system (Part II).
    Jacobsen PK
    J Renin Angiotensin Aldosterone Syst; 2005 Sep; 6(2):55-68. PubMed ID: 16470484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-grade proteinuria and microalbuminuria in renal transplantation.
    Halimi JM
    Transplantation; 2013 Jul; 96(2):121-30. PubMed ID: 23435457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of renal replacement therapy for diabetic nephropathy in the Netherlands: Dutch diabetes estimates (DUDE)-3.
    van Dijk PR; Kramer A; Logtenberg SJ; Hoitsma AJ; Kleefstra N; Jager KJ; Bilo HJ
    BMJ Open; 2015 Jan; 5(1):e005624. PubMed ID: 25636789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic nephropathy: new directions in management.
    Sirmon MD; Kirkpatrick WG
    Ren Fail; 1991; 13(2-3):51-9. PubMed ID: 1957043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnosis and management of diabetic nephropathy].
    Kitada M; Koya D
    Nihon Rinsho; 2015 Dec; 73(12):2037-43. PubMed ID: 26666150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The health care costs of diabetic nephropathy in the United States and the United Kingdom.
    Gordois A; Scuffham P; Shearer A; Oglesby A
    J Diabetes Complications; 2004; 18(1):18-26. PubMed ID: 15019595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic nephropathy-pathophysiology and management.
    Shumway JT; Gambert SR
    Int Urol Nephrol; 2002; 34(2):257-64. PubMed ID: 12775108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An update on the management of nephropathy in type 2 diabetes.
    Zhao HL; Thomas GN; Leung W; Tomlinson B; Hsu YH; Chan P
    J Chin Med Assoc; 2003 Nov; 66(11):627-36. PubMed ID: 14768849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal lactate metabolism is linked to albuminuria and kidney injury in diabetic nephropathy.
    Azushima K; Kovalik JP; Yamaji T; Ching J; Chng TW; Guo J; Liu JJ; Nguyen M; Sakban RB; George SE; Tan PH; Lim SC; Gurley SB; Coffman TM
    Kidney Int; 2023 Dec; 104(6):1135-1149. PubMed ID: 37843477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.